Nov 8, 2000|
FMCG: Much to look forward to
In the quarter ended September 2000, the fast moving consumer goods (FMCG) sector gave signs of slowing down. The consolidated numbers of the top 10 FMCG companies in India, saw a staid 5% growth in turnover. The sample includes Britannia, Colgate, Cadbury, Hindustan Lever, Indian Shaving, Nestle, P&G Hygiene, Reckitt, Smithkline Consumer and Tata Tea.
|Operating Profit (EBDIT)
|Operating Profit Margin (%)
|Profit before Tax
|Profit after Tax/(Loss)
|Net profit margin (%)
|No. of Shares (eoy) (m)
|Earnings per share* (Rs)
|Market cap to sales ratio (X)
If we were to remove HLL's results from the sample, the turnover growth would reflect an 11% growth. This is not suprising as this FMCG giant, which contributes almost 56% to the sample's turnover, saw a poor 0.4% growth in turnover during the quarter.
A slowdown in demand from the rural areas, as a result of bad monsoons in some states was largely responsible for the staid growth in turnover.
The consolidated net profit of these companies was up by 15% to Rs 5.3 bn. Notwithstanding the sluggish growth in turnover, the sector sample saw operating margins improve by 70 basis points to 14.7%. The debt servicing costs were up marginally, indicating that the FMCG sector is looking to prune its debt burden.
The depreciation costs on the other hand, surged 64%. This indicates that these companies are making new investments, underlining their confidence in the sector's future growth potential. Consequent to these results, the sample has managed to increase its EPS to Rs 31.3.
The sector is valued at a P/e multiple of 27 times its annualised September quarter earnings. The sample's market cap to sales ratio works out to be 3.1 times, which is more or less in sync with historical valuations (as on March 2000).
On the whole, it was a reasonable performance from this sector. Future growth prospects depend largely on demand from the rural segment. Further, India's GDP has shown signs of improvement, even in adverse conditions like the crude oil concerns. We believe that the sector has much to look forward to, in the near and the long term.
More Views on News
Aug 9, 2017
While GST implementation brought down volumes and profitability in the short run, Marico remains optimistic in the long run.
Dec 9, 2016
Procter & Gamble Hygiene and Health Care has announced the first quarter results of the financial year ended June 2017 (1QFY17). The company's sales rose by 12.5%YoY while net profit rose by 50.1% YoY during the quarter.
Nov 30, 2016
Nestle India declared results for the quarter ended September 2016. Here is our analysis of the result.
Nov 30, 2016
GSK Consumer Healthcare declared results for the quarter ended September 2016. The revenues dropped by 1.3% during the quarter as compared to a year ago; while the profits declined by 16.6% YoY during the quarter.
Nov 28, 2016
Marico has reported a flat topline while the bottomline has grown by 18% YoY during the quarter.
More Views on News
Aug 7, 2017
The data tells us quite a different story from the one the government is trying to project.
Aug 10, 2017
Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.
Aug 8, 2017
Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...
Aug 12, 2017
The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.
Aug 7, 2017
Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...
Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement. LEGAL DISCLAIMER:
Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here
. The performance data quoted represents past performance and does not guarantee future results.SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.
Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: firstname.lastname@example.org. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407